| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $16.5B | $15.8B | $14.9B | $15.9B | $4.5B | $4.5B | $4.6B |
| Cost of Revenue | $8.3B | $8.5B | $8.2B | $8.0B | $8.3B | $8.9B | $9.4B | $10.6B |
| Gross Profit | $8.9B | $8.1B | $7.6B | $7.0B | $7.6B | $2.0B | $2.0B | $2.0B |
| R&D Expense | — | — | — | $0.1B | — | — | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.2B | $-0.3B | $0.4B | $-2.1B | $1.7B | $-3.6B | $-0.4B | $-1.6B |
| Net Income | $1.4B | $-1.6B | $-0.6B | $-2.4B | $0.4B | $0.1B | $0.1B | $-2.9B |
| EPS (Basic) | $1.23 | $-1.45 | $-0.50 | $-2.12 | $0.38 | $0.14 | $0.10 | $-2.85 |
| EPS (Diluted) | $1.21 | $-1.45 | $-0.50 | $-2.12 | $0.38 | $0.14 | $0.10 | $-2.85 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.7B | $39.3B | $43.5B | $44.0B | $47.7B | $50.6B | $57.5B | $60.7B |
| Current Assets | $13.9B | $12.6B | $12.5B | $12.1B | $12.6B | $13.0B | $13.5B | $13.8B |
| Cash & Equivalents | $3.6B | $3.3B | $3.2B | $2.8B | $2.2B | $2.2B | $2.0B | $1.8B |
| Total Liabilities | $32.8B | $33.6B | $35.4B | $35.3B | $36.4B | $39.6B | $42.4B | $44.9B |
| Current Liabilities | $13.5B | $12.8B | $12.2B | $11.5B | $11.0B | $13.2B | $13.7B | $14.3B |
| Stockholders' Equity | $7.9B | $5.4B | $7.5B | $7.9B | $10.3B | $10.0B | $14.0B | $14.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.2B | $1.4B | $1.6B | $0.8B | $1.2B | $0.7B | $2.4B |
| Investing Cash Flow | $0.7B | $0.8B | $1.0B | $0.7B | $1.5B | $0.9B | $1.4B | $1.9B |
| Capital Expenditures | — | — | — | $0.5B | $0.6B | $0.6B | $0.5B | $0.7B |
| Financing Cash Flow | $-2.2B | $-1.8B | $-1.9B | $-1.5B | $-2.2B | $-1.9B | $-1.9B | $-3.4B |